Finance

Beta
Lists
2TK:FRA
Eledon Pharmaceuticals Inc
€3.00
+2.74%
(+0.080) 1D
Jun 12, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 2TK...
Open
€3.00
High
€3.00
Low
€3.00
Mkt. cap
275.56M
Avg. vol.
1.00
Volume
0.00
52-wk high
€3.70
52-wk low
€1.17
No. of employees
33
Open
€3.00
High
€3.00
Low
€3.00
Mkt. cap
275.56M
Avg. vol.
1.00
Volume
0.00
52-wk high
€3.70
52-wk low
€1.17
No. of employees
33
News stories
From sources across the web
About Eledon Pharmaceuticals Inc
CEO-
Employees33
Founded2004
HeadquartersIrvine, California, United States
SectorBiotechnology
Websiteeledon.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
20.28M
14.97M
17.49M
17.20M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.46M
4.10M
3.99M
3.98M
Operating expense
24.73M
19.07M
21.48M
21.18M
Total operating expenses
24.73M
19.07M
21.48M
21.18M
Operating income
-24.73M
-19.07M
-21.48M
-21.18M
Other non operating income
13.52M
1.61M
11.07M
-17.84M
EBT including unusual items
-11.22M
-17.46M
-10.41M
-39.02M
EBT excluding unusual items
-11.22M
-17.46M
-10.41M
-39.02M
Income tax expense
-
-
35.00K
-
Effective tax rate
-
-
-0.34%
-
Other operating expenses
-
-
-
-
Net income
-11.22M
-17.46M
-10.45M
-39.02M
Net profit margin
-
-
-
-
Earnings per share
-0.13
-0.21
-0.10
-0.33
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer